SIGHT SCIENCES, INC. Cost of Revenue
SIGHT SCIENCES, INC. (SGHT) reported Cost of Revenue of $2.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- SIGHT SCIENCES, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $2.01M, a 32.35% decline year-over-year.
- SIGHT SCIENCES, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $2.72M, a 12.68% increase year-over-year.
- SIGHT SCIENCES, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $2.60M, a 3.34% increase year-over-year.
- SIGHT SCIENCES, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $2.71M, a 16.65% decline year-over-year.
- SIGHT SCIENCES, INC. cost of goods and services sold for fiscal 2025 was $10.70M, a 7.63% decline from fiscal 2024.
- SIGHT SCIENCES, INC. cost of goods and services sold for fiscal 2024 was $11.58M, a 2.53% decline from fiscal 2023.
- SIGHT SCIENCES, INC. cost of goods and services sold for fiscal 2023 was $11.88M, a 3.88% decline from fiscal 2022.
- SIGHT SCIENCES, INC. cost of goods and services sold for fiscal 2022 was $12.36M, a 43.57% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.01M 10-Q · filed 2026-08-05 | $4.73M 10-Q · filed 2026-08-05 | $7.33M derived: sum of 3 quarters · filed 2026-08-05 | $10.04M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.72M 10-Q · filed 2026-05-06 | $5.32M derived: sum of 2 quarters · filed 2026-05-06 | $8.03M derived: sum of 3 quarters · filed 2026-05-06 | $11.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.31M derived: sum of 2 quarters · filed 2026-03-04 | $8.28M derived: sum of 3 quarters · filed 2026-08-05 | $10.70M 10-K · filed 2026-03-04 |
| 2025-09-30 | $2.71M 10-Q · filed 2025-11-06 | $5.69M derived: sum of 2 quarters · filed 2026-08-05 | $8.10M 10-Q · filed 2025-11-06 | $10.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.98M 10-Q · filed 2026-08-05 | $5.39M 10-Q · filed 2026-08-05 | $7.90M derived: sum of 3 quarters · filed 2026-08-05 | $11.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.41M 10-Q · filed 2026-05-06 | $4.93M derived: sum of 2 quarters · filed 2026-05-06 | $8.18M derived: sum of 3 quarters · filed 2026-05-06 | $11.20M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.76M derived: sum of 2 quarters · filed 2026-03-04 | $8.79M derived: sum of 3 quarters · filed 2026-03-04 | $11.58M 10-K · filed 2026-03-04 |
| 2024-09-30 | $3.25M 10-Q · filed 2025-11-06 | $6.28M derived: sum of 2 quarters · filed 2025-11-06 | $9.07M 10-Q · filed 2025-11-06 | $11.84M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $3.02M 10-Q · filed 2025-08-07 | $5.82M 10-Q · filed 2025-08-07 | $8.59M derived: sum of 3 quarters · filed 2025-08-07 | $11.27M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $2.79M 10-Q · filed 2025-05-08 | $5.57M derived: sum of 2 quarters · filed 2025-05-08 | $8.25M derived: sum of 3 quarters · filed 2025-05-08 | $11.63M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $5.45M derived: sum of 2 quarters · filed 2025-03-07 | $8.83M derived: sum of 3 quarters · filed 2025-03-07 | $11.88M 10-K · filed 2025-03-07 |
| 2023-09-30 | $2.68M 10-Q · filed 2024-11-07 | $6.06M derived: sum of 2 quarters · filed 2024-11-07 | $9.11M 10-Q · filed 2024-11-07 | $12.77M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $3.38M 10-Q · filed 2024-08-02 | $6.43M 10-Q · filed 2024-08-02 | $10.09M derived: sum of 3 quarters · filed 2024-08-02 | $13.02M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $3.05M 10-Q · filed 2024-05-06 | $6.71M derived: sum of 2 quarters · filed 2024-05-06 | $9.64M derived: sum of 3 quarters · filed 2024-05-06 | $12.38M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $6.59M derived: sum of 2 quarters · filed 2024-03-13 | $9.33M derived: sum of 3 quarters · filed 2024-03-13 | $12.36M 10-K · filed 2024-03-13 |
| 2022-09-30 | $2.93M 10-Q · filed 2023-11-07 | $5.66M derived: sum of 2 quarters · filed 2023-11-07 | $8.70M 10-Q · filed 2023-11-07 | $10.64M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.74M 10-Q · filed 2023-08-07 | $5.77M 10-Q · filed 2023-08-07 | $7.71M derived: sum of 3 quarters · filed 2023-08-07 | $9.77M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $3.03M 10-Q · filed 2023-05-08 | $4.97M derived: sum of 2 quarters · filed 2023-05-08 | $7.04M derived: sum of 3 quarters · filed 2023-05-08 | $9.34M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $4.00M derived: sum of 2 quarters · filed 2023-03-16 | $6.31M derived: sum of 3 quarters · filed 2023-03-16 | $8.61M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.06M 10-Q · filed 2022-11-10 | $4.37M derived: sum of 2 quarters · filed 2022-11-10 | $6.67M 10-Q · filed 2022-11-10 | $9.04M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.31M 10-Q · filed 2022-08-11 | $4.61M 10-Q · filed 2022-08-11 | $6.98M derived: sum of 3 quarters · filed 2022-08-11 | $9.60M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.30M 10-Q · filed 2022-05-10 | $4.68M derived: sum of 2 quarters · filed 2022-05-10 | $7.30M derived: sum of 3 quarters · filed 2022-05-10 | $9.38M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $5.00M derived: sum of 2 quarters · filed 2022-03-24 | $7.08M derived: sum of 3 quarters · filed 2022-03-24 | $9.21M 10-K · filed 2022-03-24 |
| 2020-09-30 | $2.62M 10-Q · filed 2021-11-10 | $4.71M derived: sum of 2 quarters · filed 2021-11-10 | $6.83M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.08M 10-Q · filed 2021-08-12 | $4.21M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |